Sign In
  • A-
  • A
  • A+
  • ع
  • A-
  • A
  • A+
  • ع
List 'Banner Items' does not exist at site with URL 'https://www.sharjah.ac.ae/en/Research/SIMHR/ddg'.

Patents

2019

  1. Rawas-Qalaji MM. Sublingual Epinephrine Compositions Including pH-Modifying Excipients and Penetration Enhancers. International Patent Pub (WIPO) # PCT/US19/56967. Filed October 18, 2019.
  2. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Pub (USPTO) # US2018/0147145 (Appl No 15/882,399). Filled January 29, 2018 and published May 31, 2018. (Letter of Allowance issued Oct 10, 2019)
  3. Rawas-Qalaji MM, Aodah AH. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets, Methods for Manufacture Thereof, and Methods for Use Thereof for Treatment of Acute Organophosphate Toxicity. European Patent Pub (EPO) # EP3200793 (B1) (Appl No 15847897). Filed October 2, 2015 and Granted August 28, 2019.
  4. Rawas-Qalaji MM, Bafail R. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets of Improved Formulation, Methods for Manufacture Thereof, and Methods for Treatment of Acute Organophosphate Toxicity. US Patent Pub (USPTO) # US2019/ 0247296. Filed September 5, 2017 and published August 5, 2019
  5. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent (USPTO) #10,251,849 (B1) (Appl No 15/262,961). Filed September 12, 2016 and Granted April 9, 2019.
  6. Rawas-Qalaji MM, Deth R. Cobalamin Composition and Use Thereof for Improving Cognitive Function in Humans. US Patent Pub (USPTO) # US2019/0030061. Filed August 30, 2018 and published January 31, 2019.

2018

  1. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Methods for Use of Epinephrine Fine Particles for Treatment of Conditions Responsive to Epinephrine. US Patent (USPTO) # US Patent (USPTO) # US 10,159,656 (B1) (Appl No 15/288,745). Filled October 17, 2016 and Granted December 25, 2018.
  2. Rawas-Qalaji MM. Sublingual Epinephrine Compositions Including pH-Modifying Excipients and Penetration Enhancers. US Provisional Patent Appl # 62/748,117. Filed October 19, 2018. 
  3. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Pub (USPTO) # US2018/0147145 (Appl No 15/882,399). Filled January 29, 2018 and published May 31, 2018.
  4. Rawas-Qalaji MM, Bafail R. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets, Methods for Manufacture Thereof, and Methods for Use Thereof for Treatment of Acute Organophosphate Toxicity. International Patent Pub (WIPO) # PCT/US17/50030 (Appl No PCT/US2017/050030). Filed September 5, 2017 and published March 8, 2018.
  5. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent (USPTO) # US 9,877,921 (B2). Filled September 15, 2016 and Granted January 30, 2018.

2017

  1. Rawas-Qalaji MM, Deth R. Cobalamin Composition and Use Thereof for Improving Cognitive Function in Humans. International Patent Pub (WIPO) # WO/2017/151723 (Appl No PCT/US2017/020125), Filed March 1, 2017 and published September 8, 2017
  2. Rawas-Qalaji MM, Aodah AH. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets, Methods for Manufacture Thereof, and Methods for Use Thereof for Treatment of Acute Organophosphate Toxicity. US Patent Pub (USPTO) # US2017/0246158 Appl No 15516444). Filed April 3, 2017 published Aug 31, 2017
  3. Rawas-Qalaji MM, Aodah AH. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets, Methods for Manufacture Thereof, and Methods for Use Thereof for Treatment of Acute Organophosphate Toxicity. European Patent Pub (EPO) # EP3200793 (Appl No 15847897). Filed April 12, 2017 and published August 9, 2017
  4. Rawas-Qalaji MM, Aodah AH. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets, Methods for Manufacture Thereof, and Methods for Use Thereof for Treatment of Acute Organophosphate Toxicity. Canadian Patent Pub (CIPO) # CA2963525. Filed April 12, 2017 and published August 9, 2017
  5. Rawas-Qalaji M.M, Simons K.J, Simons E.R, Rachid O.M, Enrique Nieves. Epinephrine Nanoparticles and Methods of Fabrication Thereof, and Methods for Use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Pub (USPTO) # US 2017/0071881 (Appl No 15/358,743). Filed November 22, 2016 and published March 16, 2017.
  6. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER Epinephrine Fine particles and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Pub (USPTO) # US2017/0020827 (Appl No 15/288,745). Filed October 17, 2016 and published January 26, 2017.
  7. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Pub (USPTO) # US2017/0000735 (Appl No 15/266,834). Filled September 15, 2016 and published January 05, 2017.

2016

  1. Rawas-Qalaji MM, Bafail R. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets, Methods for Manufacture Thereof, and Methods for Use Thereof for Treatment of Acute Organophosphate Toxicity. US Provisional Patent Appl # 62/383,115. Filed September 2, 2016. 
  2. Rawas-Qalaji MM, Aodah AH. Atropine Sulfate Rapidly-Disintegrating Sublingual Tablets, Methods for Manufacture Thereof, and Methods for Use Thereof for Treatment of Acute Organophosphate Toxicity. International Patent Pub (WIPO) # WO/2016/054504 (Appl No PCT/US2015/053713). Filed October 2, 2015 and published July 4, 2016.
  3. Rawas-Qalaji MM, Deth R. Cobalamin Composition and Use Thereof for Improving Cognitive Function in Humans. US Provisional Patent Appl # 62/301,876. Filed March 1, 2016.
  4. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Fine particles and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Pub (USPTO) # US2016/0045457 (Appl No 14/778,887). Filed September 21, 2015 and published February 18, 2016
  5. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Fine particles and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. European Patent Pub (EPO) # EP2976072 (Appl No 14768584). Filed March 24, 2014 and published January 27, 2016
  6. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER Epinephrine Fine particles and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. Canadian Patent Pub (CIPO) # CA2907770 (Appl No 2,907,770). Filed March 24, 2014 and published January 27, 2016.

2015

  1. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. US Patent Pub (USPTO) # US2015/0164827 (Appl No 14/408,038). Filed December 15, 2014 and published June 18, 2015
  2. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. European Patent Pub (EPO) # EP2861224 (Appl No 13812628). Filed June 14, 2013 and published April 22, 2015
  3. Rawas-Qalaji MM, Rachid OM, Simons KJ, Simons ER. Epinephrine Nanoparticles Methods of Fabrication Thereof, and Methods for use Thereof for Treatment of Conditions Responsive to Epinephrine. Canadian Patent Pub (CIPO) # CA2876883 (Appl No 2,876,883). Filed June 14, 2013 and published April 22, 2015.